The role of natriuretic peptides in heart failure

Daniel D. Correa de Sa, Horng Haur Chen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Heart failure is a clinical syndrome associated with progressive cardiac, vascular, and renal dysfunction. Regardless of the initial injury, investigations have demonstrated that neurohormones play an important role in the complex multiorgan and cellular adaptations. Natriuretic peptides play a key role in this process, antagonizing the actions of the renin-angiotensin-aldosterone system, thus promoting vasodilatation and natriuresis. Other important physiologic properties of the natriuretic peptides are prolusitropic, sympathoinhibitory, antiproliferative, anti-ischemic, anti-inflammatory, and antioxidative. Administering exogenous natriuretic peptide is a US Food and Drug Administration-approved therapy for patients with advanced decompensated congestive heart failure. Also, measuring natriuretic peptide levels has diagnostic and prognostic value. More studies are needed to define the full potential of this unique family of endogenous peptides.

Original languageEnglish (US)
Pages (from-to)182-189
Number of pages8
JournalCurrent Cardiology Reports
Volume10
Issue number3
DOIs
StatePublished - 2008

Fingerprint

Natriuretic Peptides
Heart Failure
Natriuresis
United States Food and Drug Administration
Renin-Angiotensin System
Vasodilation
Neurotransmitter Agents
Blood Vessels
Anti-Inflammatory Agents
Kidney
Peptides
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The role of natriuretic peptides in heart failure. / Correa de Sa, Daniel D.; Chen, Horng Haur.

In: Current Cardiology Reports, Vol. 10, No. 3, 2008, p. 182-189.

Research output: Contribution to journalArticle

Correa de Sa, Daniel D. ; Chen, Horng Haur. / The role of natriuretic peptides in heart failure. In: Current Cardiology Reports. 2008 ; Vol. 10, No. 3. pp. 182-189.
@article{1ae1d2ba4295417ea19524ed721c7758,
title = "The role of natriuretic peptides in heart failure",
abstract = "Heart failure is a clinical syndrome associated with progressive cardiac, vascular, and renal dysfunction. Regardless of the initial injury, investigations have demonstrated that neurohormones play an important role in the complex multiorgan and cellular adaptations. Natriuretic peptides play a key role in this process, antagonizing the actions of the renin-angiotensin-aldosterone system, thus promoting vasodilatation and natriuresis. Other important physiologic properties of the natriuretic peptides are prolusitropic, sympathoinhibitory, antiproliferative, anti-ischemic, anti-inflammatory, and antioxidative. Administering exogenous natriuretic peptide is a US Food and Drug Administration-approved therapy for patients with advanced decompensated congestive heart failure. Also, measuring natriuretic peptide levels has diagnostic and prognostic value. More studies are needed to define the full potential of this unique family of endogenous peptides.",
author = "{Correa de Sa}, {Daniel D.} and Chen, {Horng Haur}",
year = "2008",
doi = "10.1007/s11886-008-0032-2",
language = "English (US)",
volume = "10",
pages = "182--189",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - The role of natriuretic peptides in heart failure

AU - Correa de Sa, Daniel D.

AU - Chen, Horng Haur

PY - 2008

Y1 - 2008

N2 - Heart failure is a clinical syndrome associated with progressive cardiac, vascular, and renal dysfunction. Regardless of the initial injury, investigations have demonstrated that neurohormones play an important role in the complex multiorgan and cellular adaptations. Natriuretic peptides play a key role in this process, antagonizing the actions of the renin-angiotensin-aldosterone system, thus promoting vasodilatation and natriuresis. Other important physiologic properties of the natriuretic peptides are prolusitropic, sympathoinhibitory, antiproliferative, anti-ischemic, anti-inflammatory, and antioxidative. Administering exogenous natriuretic peptide is a US Food and Drug Administration-approved therapy for patients with advanced decompensated congestive heart failure. Also, measuring natriuretic peptide levels has diagnostic and prognostic value. More studies are needed to define the full potential of this unique family of endogenous peptides.

AB - Heart failure is a clinical syndrome associated with progressive cardiac, vascular, and renal dysfunction. Regardless of the initial injury, investigations have demonstrated that neurohormones play an important role in the complex multiorgan and cellular adaptations. Natriuretic peptides play a key role in this process, antagonizing the actions of the renin-angiotensin-aldosterone system, thus promoting vasodilatation and natriuresis. Other important physiologic properties of the natriuretic peptides are prolusitropic, sympathoinhibitory, antiproliferative, anti-ischemic, anti-inflammatory, and antioxidative. Administering exogenous natriuretic peptide is a US Food and Drug Administration-approved therapy for patients with advanced decompensated congestive heart failure. Also, measuring natriuretic peptide levels has diagnostic and prognostic value. More studies are needed to define the full potential of this unique family of endogenous peptides.

UR - http://www.scopus.com/inward/record.url?scp=45849110678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45849110678&partnerID=8YFLogxK

U2 - 10.1007/s11886-008-0032-2

DO - 10.1007/s11886-008-0032-2

M3 - Article

C2 - 18489861

AN - SCOPUS:45849110678

VL - 10

SP - 182

EP - 189

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 3

ER -